Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb:69:14-27.
doi: 10.1016/j.cytogfr.2022.08.001. Epub 2022 Aug 20.

T cell receptor signaling in the differentiation and plasticity of CD4+ T cells

Affiliations
Review

T cell receptor signaling in the differentiation and plasticity of CD4+ T cells

Heikrujam Thoihen Meitei et al. Cytokine Growth Factor Rev. 2023 Feb.

Abstract

CD4+ T cells are critical components of the adaptive immune system. The T cell receptor (TCR) and co-receptor signaling cascades shape the phenotype and functions of CD4+ T cells. TCR signaling plays a crucial role in T cell development, antigen recognition, activation, and differentiation upon recognition of foreign- or auto-antigens. In specific autoimmune conditions, altered TCR repertoire is reported and can predispose autoimmunity with organ-specific inflammation and tissue damage. TCR signaling modulates various signaling cascades and regulates epigenetic and transcriptional regulation during homeostasis and disease conditions. Understanding the mechanism by which coreceptors and cytokine signals control the magnitude of TCR signal amplification will aid in developing therapeutic strategies to treat inflammation and autoimmune diseases. This review focuses on the role of the TCR signaling cascade and its components in the activation, differentiation, and plasticity of various CD4+ T cell subsets.

Keywords: Foxp3; T cell receptor; Th17 cells; Tregs.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement The authors declare no commercial or financial conflict of interest.

Publication types

Substances